Hydrops lysosomalis generalisatus--an underestimated side effect of hydroxyethyl starch therapy?

Eur J Haematol. 2006 Jul;77(1):83-5. doi: 10.1111/j.1600-0609.2006.00657.x. Epub 2006 Apr 11.

Abstract

Hydroxyethyl starch (HES) is usually considered to be associated with limited side effects. Generalized foamy cell macrophage syndrome after HES therapy has rarely been reported since Schaefer first described it as 'hydrops lysosomalis generalisatus' in 1982. We present a 19-yr-old male who received large amounts of HES. A bone marrow and a liver biopsy were performed because of persistent thrombocytopenia and liver dysfunction. We found severe infiltration of foamy cell degenerated macrophages in both organ systems, indicating that sequelae of HES therapy have to be included in the differential diagnosis of bone marrow and liver dysfunction.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bone Marrow / pathology
  • Edema / chemically induced*
  • Edema / pathology
  • Foam Cells / pathology
  • Humans
  • Hydroxyethyl Starch Derivatives / adverse effects*
  • Liver / pathology
  • Male

Substances

  • Hydroxyethyl Starch Derivatives